FDA Adverse Event Injury Summary report: N

EPSILA EV¿

MDR report key: 21590080 · Received March 12, 2025

Report

Report Number
2649622-2025-07106
Event Type
Injury
Date Received
March 12, 2025
Date of Event
February 7, 2025
Report Date
April 28, 2025
Manufacturer
MPRI
Product Code
NVY
PMA / PMN Number
P220012
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID DVEA3E4 (EVX603213S); PRODUCT TYPE: 0235-ICD; IMPLANT DATE (B)(6) 2025; PRODUCT ID EV240163 (EVL006197V); PRODUCT TYPE: 0264-LEAD-HV; IMPLANT DATE (B)(6) 2025; EXPLANT DATE MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT INITIALLY POST IMPLANT OF THE EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) SYSTEM THE PATIENT WAS NOTED TO BE STABLE. SHORTLY AFTER THE PATIENT EXHIBITED SHORTNESS OF BREATH AND WAS NON-RESPONSIVE TO OXYGEN SUPPLEMENTATION AND REQUIRED INTUBATION. THE PATIENT WENT INTO CARDIAC ARREST AND DEVELOPED MULTIPLE RUNS OF MONOMORPHIC VENTRICULAR TACHYCARDIA (VT) AND POLYMORPHIC VT WHICH WERE EVENTUALLY SUCCESSFULLY CARDIOVERTED VIA CARDIOPULMONARY RESUSCITATION. AN X-RAY SHOWED LEFT PLEURAL EFFUSION. THE PATIENT WAS RESUSCITATED WITH MULTIPLE INTRAVENOUS MEDICATIONS AND INTERVENTIONS. INCLUDING A LEFT SIDED CHEST TUBE BEING PLACED, BEING EXTERNALLY SHOCKED SEVEN TIMES, AND A STELLATE GANGLION BLOCK PERFORMED. THE NEXT DAY, NO FURTHER VT WAS REPORTED THE PATIENT REMAINED INTUBATED BUT WAS AWAKE AND RESPONSIVE. THE FOLLOWING DAY, THE PATIENT WAS EXTUBATED AND RESPONDING APPROPRIATELY. THE EV ICD SYSTEM REMAINS IN USE. THE PATIENT IS A PARTICIPANT IN A CLINICAL STUDY. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT INITIALLY POST IMPLANT OF THE EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) SYSTEM THE PATIENT WAS NOTED TO BE STABLE. SHORTLY AFTER THE PATIENT EXHIBITED SHORTNESS OF BREATH AND WAS NON-RESPONSIVE TO OXYGEN SUPPLEMENTATION AND REQUIRED INTUBATION. THE PATIENT WENT INTO CARDIAC ARREST AND DEVELOPED MULTIPLE RUNS OF MONOMORPHIC VENTRICULAR TACHYCARDIA (VT) AND POLYMORPHIC VT WHICH WERE EVENTUALLY SUCCESSFULLY CARDIOVERTED VIA CARDIOPULMONARY RESUSCITATION. AN X-RAY SHOWED LEFT PLEURAL EFFUSION. THE PATIENT WAS RESUSCITATED WITH MULTIPLE INTRAVENOUS MEDICATIONS AND INTERVENTIONS. INCLUDING A LEFT SIDED CHEST TUBE BEING PLACED, BEING EXTERNALLY SHOCKED SEVEN TIMES, AND A STELLATE GANGLION BLOCK PERFORMED. THE NEXT DAY, NO FURTHER VT WAS REPORTED THE PATIENT REMAINED INTUBATED BUT WAS AWAKE AND RESPONSIVE. THE FOLLOWING DAY, THE PATIENT WAS EXTUBATED AND RESPONDING APPROPRIATELY. THE EV ICD SYSTEM REMAINS IN USE. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.  THE PATIENT IS A PARTICIPANT IN A CLINICAL STUDY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1689916 EPSILA EV¿ PERMANENT DEFIBRILLATOR ELECTRODES NVY MPRI EAZ101

Patients

Seq Age Sex Outcome Treatment
1 52 YR Male Required Intervention| H| L SEE H11...